icon-folder.gif   Conference Reports for NATAP  
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
June 23-26 2021
Back grey_arrow_rt.gif
Safety and Efficacy of Bulevirtide Monotherapy and in Combination with Peginterferon Alfa-2a in Patients with Chronic Hepatitis Delta: 24 Weeks Interim Data of MYR204 Phase 2b Study
  EASL: Bulevirtide Monotherapy at Low and High Doses in Patients With Chronic Hepatitis Delta: 24-Week Interim Data of the Phase 3 MYR301 Study - (06/24/21)
The Digital International Liver Congress, 23-26 June 2021
Tarik Asselah1, Sorin Stefan Arama2, Pavel Bogomolov3, Marc Bourliere4, Helene Fontaine5, George Sebastian Gherlan6,7, Vladimir Gorodin8, Marie-NoŽlle Hilleret9, Stefan Lazar10, Nina Mamonova11, Morozov Viacheslav12, Victor Pantea13, Gheorghe Placinta13, Jerome Gournay14, Francois Raffi14, Vlad Ratziu15, Christiane Stern15, Olga Sagalova16, Didier Samuel17, Tatyana Stepanova18, Vladimir Syutkin19, Adrian Streinu-Cercel2, Fabien Zoulim20, Dominique Roulot21
1Hopital Beaujon APHP, Universite de Paris, INSERM, Clichy, France; 2Matei Bals National Institute of Infectious Diseases, Bucharest, Romania; 3M.F. Vladimirsky Moscow Regional Research and Clinical Institute, Moscow, Russian Federation; 4Hopital Saint Joseph Marseille, France; 5Hopital Cochin, Paris, France; 6"Carol Davila" University of Medicine and Pharmacy, Bucharest; 7Dr. Victor Babes Foundation, Bucharest; 8"Specialized Clinical Infectious Diseases Hospital", Krasnodar, Russian Federation; 9Centre Hospitalier Universitaire Grenoble Alpes, Grenoble, France; 10Dr. Victor Babes Foundation, Infectious and Tropical Diseases Hospital, Bucharest; 11National Research Medical Center for Phthisiopulmonology and Infectious Diseases, Moscow; 12Hepatolog, LLC, Samara, Russian Federation; 13Infectious Clinical Hospital "T. Ciorba", Chisinau, Moldova; 14Nantes University Hospital, Nantes, France; 15CH Pitie-Salpetriere, Paris; 16Southern Ural State Medical University, Chelyabinsk, Russian Federation; 17Universite Paris Saclay, Villejuif, France; 18Clinic of Modern Medicine, Moscow; 19Institute of Emergency Medicine n.a. NV Sklifosovsky, Moscow; 20Hospital Croix Rousee, Lyon, France; 21Universite Sorbonne Paris Nord, Bobigny, France